Study population
mental illness, seizures, pain, lung cancer, allergic reactions
LUNG CANCER, ISCHEMIC HEART DISEASE, ALLERGIC REACTION
In this study, we included consecutive patients who (1) were ≥ 18 years of age; whose (2) ASA classification was between I-III; whose (3) BMI index (body mass index) did not exceed 30; and who (4) were able to sign the informed consent form independently. We excluded patients who (1) were receiving continuous infusion of sedative agents and pain relievers; (2) had severe ischemic heart disease, mental illness, pregnancy, seizures, or increased intracranial pressure; and (3) had a history of allergic reactions to the drugs planned for the study.A total of 46 patients with lung cancer were observed from Mar 2022 to Feb 2023, and 44 patients met the inclusion criteria and were included in the final analysis.